Antioxidant Effect of Acetylsalicylic and Salicylic Acid in Rat Brain Slices Subjected to Hypoxia

Journal of Neuroscience Research

Volumn 75, Issue 2, 2004, Pages 280-290

  De La Cruz, J P ^a   Guerrero, A ^a   Gonzalez Correa J A ^a   Arrebola, M M ^a   Sanchez De La Cuesta F ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Acetylsalicylic acid; Brain hypoxia; Brain oxidative stress; Nitric oxide; Salicylic acid

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; NITROGEN; SALICYLIC ACID;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD; BRAIN HYPOXIA; BRAIN PERFUSION; BRAIN SLICE; CELL DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG COMBINATION; DRUG EFFECT; ENZYME ACTIVITY; EVALUATION; IN VITRO STUDY; LIPID PEROXIDATION; MALE; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; SHORT SURVEY; TIME;

ANIMALS; ASPIRIN; CELL DEATH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GLUTATHIONE; HYPOXIA, BRAIN; LIPID PEROXIDATION; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; SALICYLIC ACID;

EID: 0347990335     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10851     Document Type: Short Survey

References (47)

1. Anasuma M, Nishibayashi-Asanuma S, Miyazaki I, Cono M, Ogawa N. 2001. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76:1895-1904.
2. Antithrombotic Trialists' Collaboration. 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86.
3. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. 1998. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391:281-285.
4. Bossman HB, Hemsworth BD. 1969. Structure and function of nervous system. London: Academic Press. p 1-24.
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Cai Y, Sohlenius AK, Andersson K, Sundberg C, DePierre JW. 1994. Effects of acetylsalicylic acid on parameters related to peroxisome proliferation in mouse liver. Biochem Pharmacol 47:2213-2219.
7. Castillo J, Rama R, Dávalos A. 2000. Nitric oxide-related brain damage in acute ischemic stroke. Stroke 31:852-857.
8. De Cristobal J, Cárdenas A, Lizasoain I, Leza JC, Fernández-Tomé P, Lorenzo P, Moro MA. 2002. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of acetylsalicylic acid in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke 33:261-267.
9. De Gaetano G, Cerletti C, Dejana E, Lattini R. 1985. Pharmacology of platelet inhibition in humans: implications of the salicylate-acetylsalicylic acid interaction. Circulation 72:1185-1193.
10. De La Cruz JP, Blanco E, Sánchez De La Cuesta F. 2000a. Effect of dipyridamole and acetylsalicylic acid on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 397:35-41.
11. De La Cruz JP, Carrasco T, Ortega G, Sánchez De La Cuesta F. 1992. Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes. Lipids 27:192-194.
12. De La Cruz JP, Guerrero A, Gonzalez-Correa JA, Marquez E, Nacle I, Sánchez De La Cuesta F. 2002a. Differences in the effect of two preparations of extended-release aspirin (75 mg) on platelet aggregation, prostanoids and nitric oxide production in humans. Eur J Clin Pharmacol 57:775-780.
13. De La Cruz JP, Guerrero A, Gonzalez-Correa JA, Marquez E, Martos F, Sánchez De La Cuesta F. 2003. Effects of 150 mg extended-release aspirin on prostanoid and nitric oxide production in healthy volunteers. Fundam Clin Pharmacol 17:363-372.
14. De La Cruz JP, Guerrero A, Paniego MJ, Arranz I, Moreno A, Sánchez De La Cuesta F. 2002b. Effect of acetylsalicylic acid on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn Schmiedebergs Arch Pharmacol 365:96-101.
15. De La Cruz JP, Pavía J, González-Correa JA, Ortiz P, Sánchez De La Cuesta F. 2000b. Effects of chronic administration of S-adenosyl-1-methionine on brain oxidative stress in rats. Naunyn Schmiedebergs Arch Pharmacol 361:47-52.
16. De La Cruz JP, Villalobos MA, Cuerda MA, Guerrero A, Sánchez De La Cuesta F. 2002c. Protective effect of S-adenosyl-L-methionine in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation. Neurosci Lett 318:103-107.
17. De la Cruz JP, Villalobos MA, Sedeño G, Sánchez De La Cuesta F. 1998. Effect of propofol on oxidative stress in an in vitro model of hypoxia-reoxygenation in the rat brain. Brain Res 800:136-144.
18. 2 inhibitor, of both cirrhosis and enzyme-altered nodules caused by a choline-deficient. L-amino acid-deficient diet in rats. Carcinogenesis 17:467-475.
19. Flohé L, Gunzler WA. 1985. Assays of glutathione peroxidase. Methods Enzymol 105:114-121.
20. Forman LJ, Liu P, Nagele RG, Yin K, Wong PY. 1998. Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem Res 23:141-148.
21. Gálvez J, De la Cruz JP, Zarzuelo A, Sánchez-Medina F, Jiménez J, Sánchez De La Cuesta F. 1994. Oral administration of quercitrin modifies intestinal oxidative status in rats. Gen Pharmacol 25:1237-1243.
22. Grilli M, Pizzi M, Memo M, Spano P. 1996. Neuroprotection by acetylsalicylic acid and sodium salicylate through blockade of NF-kappa B activation. Science 274:1383-1385.
23. Grotta JC, Lemak NA, Gary H, Fields WS, Vital D. 1985. Does platelet antiaggregant therapy lessen the severity of stroke? Neurology 35:632-636.
24. Hall ED, Andrus PK, Althaus JS, von Voigtlander PF. 1993. Hydroxyl radical production and lipid peroxidation parallel selective post-ischemic vulnerability in gerbil brain. J Neurosci Res 34:107-112.
25. Hissin PJ, Hill R. 1976. A fluorimetric method of determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226.
26. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. 1992. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281:419-424.
27. Khayyam N, Thavendiranathan P, Carmichael FJ, Kus B, Jay B, Burnham WM. 1999. Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. Neuroreport 10:371-374.
28. Kim SJ, Kim YK, Takagi G, Huang CH, Geng YJ, Vatner SF. 2002. Enhanced iNOS function in myocytes one day after brief ischemic episode. Am J Physiol Heart Circ Physiol 282:423-428.
29. Kontos HA. 2001. Oxygen radicals in cerebral ischemia: the 2001 Willis Lecture. Stroke 32:2712-2716.
30. Levy G. 1976. Pharmacokinetics of acetylsalicylic acid in man. J Invest Dermatol 67:667-669.
31. Li PA, Liu GJ, He QP, Floyd RA, Siesjo BK. 1999. Production of hydroxyl free radicals by brain tissues in hyperglycemic rats subjected to transient forebrain ischemia. Free Radic Biol Med 27:1033-1040.
32. Lobner D. 2000. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods 96:147-152.
33. Lopez-Farré A, Caramelo C, Esteban A, Alberola ML, Millas I, Monton M, Casado S. 1995. Effect of acetylsalicylic acid on platelet-neutrophil interaction. Role of nitric oxide and endothelin-1. Circulation 91:2080-2088.
34. Losche W, Pescarmona GP, Hofmann J, Bosia A, Arese P, Thielmann K, Till U. 1984. Effect of acetylsalicylic acid on glutathione consumption and hexose monophosphate shunt during arachidonic acid induced stimulation of human blood platelets. Biomed Biochim Acta 43:1325-1328.
35. Moro MA, De Alba J, Cárdenas A, De Cristóbal J, Leza JC, Lizasoain I, Díaz-Guerra MJ, Boscá L, Lorenzo P. 2000. Mechanisms of the neuroprotective effect of acetylsalicylic acid after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology 39:1309-1318.
36. Moro MA, De Alba J, Leza JC, Lorenzo P, Fernández AP, Ventura ML, Boscá L, Rodrigo J, Lizasoain I. 1998. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci 10:445-456.
37. Murdoch J, Hall R. 1990. Brain protection: physiological and pharmacological considerations. Part I: The physiology of brain injury. Can J Anaesth 37:663-671.
38. Peterson DA, Gerrard JM, Rao GH, White JG. 1981. Salicylic acid inhibition of the irreversible effect of acetylsalicylic acid on prostaglandin synthetase may be due to competition for the enzyme cationic binding site. Prostaglandins Med 6:161-164.
39. Piantadosi CA, Zhang J, Demchenko IY. 1997. Production of hydroxyl radical in the hippocampus after CO hypoxia or hypoxia in the rat. Free Radic Biol Med 22:725-732.
40. Riepe MW, Kasischke K, Raupach A. 1997. Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia. Stroke 28:2006-2011.
41. Roth GJ, Stanford N, Majerus PW. 1975. Acetylation of prostaglandin synthase by acetylsalicylic acid. Proc Natl Acad Sci USA 72:3073-3076.
42. Rumble RH, Roberts MS, Wanwimolruk S. 1981. Determination of acetylsalicylic acid and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J Chromatogr 225:252-260.
43. Sagone AL, Husney RM. 1987. Oxidation of salicylates by stimulated granulocytes: evidence that these drug act as free radical scavengers in biological systems. J Immunol 138:2177-2183.
44. Sánchez de Miguel L, de Frutos T, González-Ferná ndez F, del Pozo V, Lahoz C, Jiménez A, Rico L, García R, Aceituno E, Millas I, Gómez J, Farré J, Casado S, López-Farré A. 1999. Acetylsalicylic acid inhibits inducible nitric oxide synthase expression and tumour necrosis factor-alpha release by cultured smooth muscle cells. Eur J Clin Invest 29:93-99.
45. van Bree L, Groot EJ, De Vries J. 1989. Reduction by acetylsalicylic acid of paracetamol-induced hepatic glutathione depletion in rats treated with 4,4′-dichlorobiphenyl, phenobarbitone and pregnenolone-16-alpha-carbonitrile. J Pharm Pharmacol 41:343-345.
46. Venturini L, Sparber SB. 2001. Salicylate and cocaine: interactive toxicity during chicken mid-embryogenesis. Free Radic Biol Med 30:198-207.
47. Warholm M, Guthenberg C, von Bahr C, Mannervik B. 1985. Glutathione transferases from human liver. Methods Enzymol 113:449-503.